Daniel Bensen - 06 Sep 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Operating Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
4
Filing time
08 Sep 2022, 17:36:11 UTC
Previous filing
04 Nov 2021
Next filing
23 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +105,000 $0.000000 105,000 06 Sep 2022 Common Stock 105,000 $7.14 Direct F1
transaction TYRA Stock Option (Right to Buy) Award $0 +249,532 $0.000000 249,532 06 Sep 2022 Common Stock 249,532 $7.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F2 1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.